Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

CUSIP: 48576U106

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
+14,250,811
Put/Call ratio
45%
SEC-reported price per share
$7.37
Number of holders
134
Value change
+$108,241,216
Number of buys
65
Open additional details 1 more signal available
Number of sells
69
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
22,658,403

Security key

48576U106

Report period

Q1 2022

Institutions

134

Top holders

10

Ownership snapshot

Top reported holders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F Lead comparable stake: 39% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 39%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock Finance, Inc. 39%
STATE STREET CORP 24%
Palo Alto Investors LP 24%
VANGUARD GROUP INC 15%
Rubric Capital Management LP 12%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
39%
$57,343,000
8,918,206 shares
31 Dec 2021
STATE STREET CORP
13F
Company
13F
24%
$35,453,000
5,513,680 shares
31 Dec 2021
Palo Alto Investors LP
13F
Company
13F
24%
$35,175,000
5,470,452 shares
31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
15%
$21,597,000
3,358,807 shares
31 Dec 2021
Rubric Capital Management LP
13F
Company
13F
12%
$17,891,000
2,782,443 shares
31 Dec 2021
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
13F
8.7%
$12,613,000
1,961,588 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
134
Shares
68,286,528
Rows available
134
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q4 2025 Across Filers

Q4 2025 holders
0
Q1 2022 holders
134
Holder diff
134
Investor Q4 2025 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2025 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .